Avalanche Biotechnologies Inc Stock Nasdaq
Equities
US05337G1076
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 195M |
---|---|---|---|---|---|
Net income 2024 * | -111M | Net income 2025 * | -143M | EV / Sales 2024 * | - |
Net cash position 2024 * | 149M | Net cash position 2025 * | 136M | EV / Sales 2025 * | 5.94 x |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-1.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on Avalanche Biotechnologies Inc
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 22-12-11 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-04-15 | |
Clarence Machado
CHM | Chairman | 60 | 17-03-13 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
1st Jan change | Capi. | |
---|---|---|
-2.75% | 103B | |
+0.51% | 95.71B | |
+1.43% | 22.02B | |
-17.30% | 20.9B | |
-9.30% | 17.85B | |
-42.83% | 16.21B | |
-15.48% | 15.52B | |
+4.86% | 13.86B | |
+33.05% | 12.04B |